A Comparative Analysis of the Effects of Haloperidol and Dexmedetomidine on QTc Interval Prolongation during Delirium Treatment in Intensive Care Units

1. Krahne D, Heymann A, Spies C. How to monitor delirium in the ICU and why it is important. Clinl Effect Nurs. 2006;9:269–79. KrahneD HeymannA SpiesC How to monitor delirium in the ICU and why it is important Clinl Effect Nurs 2006 9 269 79 Search in Google Scholar

2. Urden L, Stacy K, Rajabpour NM, et al. Study of Predictors of Delirium Incidence in Hospitalized Patients In Intensive Care Units. Nurs Midwife Commun. 2014;26(18):25–35. UrdenL StacyK RajabpourNM Study of Predictors of Delirium Incidence in Hospitalized Patients In Intensive Care Units Nurs Midwife Commun 2014 26 18 25 35 Search in Google Scholar

3. Javaherforooshzadeh F, Monajemzadeh SA, Soltanzadeh M, Janatmakan F, Salari A, Saeed H. A Comparative Study of the Amount of Bleeding and Hemodynamic Changes between Dexmedetomidine Infusion and Remifentanil Infusion for Controlled Hypotensive Anesthesia in Lumbar Discopathy Surgery: A Double-Blind, Randomized, Clinical Trial. Anesth Pain Med. 2018;8(2):e66959. JavaherforooshzadehF MonajemzadehSA SoltanzadehM JanatmakanF SalariA SaeedH A Comparative Study of the Amount of Bleeding and Hemodynamic Changes between Dexmedetomidine Infusion and Remifentanil Infusion for Controlled Hypotensive Anesthesia in Lumbar Discopathy Surgery: A Double-Blind, Randomized, Clinical Trial Anesth Pain Med 2018 8 2 e66959 Search in Google Scholar

4. Al Huraizi AR, Al-Maqbali JS, Al Farsi RS, et al. Delirium and Its Association with Short- and Long-Term Health Outcomes in Medically Admitted Patients: A Prospective Study. J Clin Med. 2023;12(16):5346. Al HuraiziAR Al-MaqbaliJS Al FarsiRS Delirium and Its Association with Short- and Long-Term Health Outcomes in Medically Admitted Patients: A Prospective Study J Clin Med 2023 12 16 5346 Search in Google Scholar

5. Nelson S, Muzyk AJ, Bucklin MH, Brudney S, Gagliardi JP. Defining the Role of Dexmedetomidine in the Prevention of Delirium in the Intensive Care Unit. BioMed Res Int. 2015;2015:635737. NelsonS MuzykAJ BucklinMH BrudneyS GagliardiJP Defining the Role of Dexmedetomidine in the Prevention of Delirium in the Intensive Care Unit BioMed Res Int 2015 2015 635737 Search in Google Scholar

6. Daou M, Telias I, Younes M, Brochard L, Wilcox ME. Abnormal Sleep, Circadian Rhythm Disruption, and Delirium in the ICU: Are They Related?. Front Neurol. 2020;11:549908. DaouM TeliasI YounesM BrochardL WilcoxME Abnormal Sleep, Circadian Rhythm Disruption, and Delirium in the ICU: Are They Related? Front Neurol 2020 11 549908 Search in Google Scholar

7. Jeong IS, Cho MK. Factors Affecting Delirium in ICU Patients. Int J Environ Res Public Health. 2023;20(10):5889. JeongIS ChoMK Factors Affecting Delirium in ICU Patients Int J Environ Res Public Health 2023 20 10 5889 Search in Google Scholar

8. Tran A, Blinder H, Hutton B et al. Alpha-2 agonists for sedation in mechanically ventilated neurocritical care patients: a systematic review protocol. Syst Rev. 2016:5(1):154 TranA BlinderH HuttonB Alpha-2 agonists for sedation in mechanically ventilated neurocritical care patients: a systematic review protocol Syst Rev 2016 5 1 154 Search in Google Scholar

9. Pedersen SS, Kirkegaard T, Jørgensen MB, Jørgensen VL. Effects of a screening and treatment protocol with haloperidol on post-cardiotomy delirium: a prospective cohort study. Interact Cardiovasc Thorac Surg. 2014;18(4):438–445. PedersenSS KirkegaardT JørgensenMB JørgensenVL Effects of a screening and treatment protocol with haloperidol on post-cardiotomy delirium: a prospective cohort study Interact Cardiovasc Thorac Surg 2014 18 4 438 445 Search in Google Scholar

10. Pisani MA, Araujo KL, Murphy TE. Association of cumulative dose of haloperidol with next-day delirium in older medical ICU patients. Crit. Care Med. 2015;43(5):996–1002. PisaniMA AraujoKL MurphyTE Association of cumulative dose of haloperidol with next-day delirium in older medical ICU patients Crit. Care Med 2015 43 5 996 1002 Search in Google Scholar

11. van den Boogaard M, Schoonhoven L, van Achterberg T, van der Hoeven JG, Pickkers P. Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Critical care. 2013;17(1):R9. van den BoogaardM SchoonhovenL van AchterbergT van der HoevenJG PickkersP Haloperidol prophylaxis in critically ill patients with a high risk for delirium Critical care 2013 17 1 R9 Search in Google Scholar

12. Page VJ, Ely EW, Gates S, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir. Med. 2013;1(7):515–523. PageVJ ElyEW GatesS Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial Lancet Respir. Med. 2013 1 7 515 523 Search in Google Scholar

13. Leuch S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet. 2013;382(9896):951–962. LeuchS CiprianiA SpineliL Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis The Lancet 2013 382 9896 951 962 Search in Google Scholar

14. Tamang K, Kc B, Kuikel S, Thapa S. Haloperidol-induced sudden cardiac arrest in a recently detected HIV and hepatitis C patient: A unique case report. SAGE Open Med Case Rep. 2023;11:2050313X231220792. TamangK KcB KuikelS ThapaS Haloperidol-induced sudden cardiac arrest in a recently detected HIV and hepatitis C patient: A unique case report SAGE Open Med Case Rep 2023 11 2050313X231220792 Search in Google Scholar

15. Collet MO, Caballero J, Sonneville R, et al. Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study. Intensive Care Med 2018; 44(7): 1081–1089. ColletMO CaballeroJ SonnevilleR Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study Intensive Care Med 2018 44 7 1081 1089 Search in Google Scholar

16. Dotson B. Comparing Dexmedetomidine With Haloperidol for the Treatment of Hyperactive Delirium in Nonintubated ICU Patients. Crit Care Med. 2016;44(12):1259–60. DotsonB Comparing Dexmedetomidine With Haloperidol for the Treatment of Hyperactive Delirium in Nonintubated ICU Patients Crit Care Med 2016 44 12 1259 60 Search in Google Scholar

17. Keating GM. Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting. Drugs. 2015;75(10):1119–30. KeatingGM Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting Drugs 2015 75 10 1119 30 Search in Google Scholar

18. Reade MC, Eastwood GM, Bellomo R, et al. Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial. JAMA. 2016;315(14):1460–8. ReadeMC EastwoodGM BellomoR Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial JAMA 2016 315 14 1460 8 Search in Google Scholar

19. Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 1997;86:331–345. JalonenJ HynynenM KuitunenA Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting Anesthesiology 1997 86 331 345 Search in Google Scholar

20. Kim Y, Kim SY, Lee JS, Kong HJ, Han DW. Effect of dexmedetomidine on the corrected QT and Tp-e intervals during spinal anesthesia. Yonsei Med J. 2014;55(2):517–522. KimY KimSY LeeJS KongHJ HanDW Effect of dexmedetomidine on the corrected QT and Tp-e intervals during spinal anesthesia Yonsei Med J 2014 55 2 517 522 Search in Google Scholar

21. Raschi E, Poluzzi E, Godman B, et al. Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe. PLoS ONE 2013;8(11):81208. RaschiE PoluzziE GodmanB Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe PLoS ONE 2013 8 11 81208 Search in Google Scholar

22. Metzger E, Friedman R. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. Journal of Clin. Psychopharmacol. 1993;13(2):128–132. MetzgerE FriedmanR Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill Journal of Clin. Psychopharmacol. 1993 13 2 128 132 Search in Google Scholar

23. Perrault LP, Denault AY, Carrier M, Cartier R, Bélisle S. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery. Can J Anaesth. 2000;47(3):251–254. PerraultLP DenaultAY CarrierM CartierR BélisleS Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery Can J Anaesth 2000 47 3 251 254 Search in Google Scholar

24. O’Brien JM, Rockwood RP, Suh KI. Haloperidol-induced torsade de pointes. Ann Pharmacother. 1999;33(10):1046–1050. O’BrienJM RockwoodRP SuhKI Haloperidol-induced torsade de pointes Ann Pharmacother 1999 33 10 1046 1050 Search in Google Scholar

25. Li M, Ramos LG. Drug-Induced QT Prolongation And Torsades de Pointes. P T. 2017;42(7):473–477. LiM RamosLG Drug-Induced QT Prolongation And Torsades de Pointes P T 2017 42 7 473 477 Search in Google Scholar

26. Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2010;55(9):934–947. DrewBJ AckermanMJ FunkM Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation J Am Coll Cardiol 2010 55 9 934 947 Search in Google Scholar

27. Burns KM, Greene EA. Long QT syndrome unmasked by dexmedetomidine: a case report. Congenital heart disease. 2014;9(1):E11–E15. BurnsKM GreeneEA Long QT syndrome unmasked by dexmedetomidine: a case report Congenital heart disease 2014 9 1 E11 E15 Search in Google Scholar

28. Görges M, Whyte SD, Sanatani S, Dawes J, Montgomery CJ, Ansermino JM. Changes in QTc associated with a rapid bolus dose of dexmedetomidine in patients receiving TIVA: a retrospective study. Paediatric anaesthesia. 2015;25(12):1287–1293. GörgesM WhyteSD SanataniS DawesJ MontgomeryCJ AnserminoJM Changes in QTc associated with a rapid bolus dose of dexmedetomidine in patients receiving TIVA: a retrospective study Paediatric anaesthesia 2015 25 12 1287 1293 Search in Google Scholar

29. Fujii E, Fujino K, Fujii M, Furuno M, Sugimoto Y, Takabuchi S, et al. Dexmedetomidine attenuates the positive chronotropic effects of intravenous atropine in patients with bradycardia during spinal anaesthesia: a retrospective study. JA Clinical Reports. 2018;4(1):1–6. FujiiE FujinoK FujiiM FurunoM SugimotoY TakabuchiS Dexmedetomidine attenuates the positive chronotropic effects of intravenous atropine in patients with bradycardia during spinal anaesthesia: a retrospective study JA Clinical Reports 2018 4 1 1 6 Search in Google Scholar

30. Grmec S, Mally S, Klemen P. Glasgow Coma Scale score and QTc interval in the prognosis of organophosphate poisoning. Acad Emerg Med. 2004;11(9):925–930. GrmecS MallyS KlemenP Glasgow Coma Scale score and QTc interval in the prognosis of organophosphate poisoning Acad Emerg Med 2004 11 9 925 930 Search in Google Scholar

31. George TK, Chase D, Peter JV, et al. Association between a prolonged corrected QT interval and outcomes in patients in a medical Intensive Care Unit. Indian J Crit Care Med. 2015;19(6):326–332) GeorgeTK ChaseD PeterJV Association between a prolonged corrected QT interval and outcomes in patients in a medical Intensive Care Unit Indian J Crit Care Med 2015 19 6 326 332 Search in Google Scholar

32. Ye M, Zhang J, Liu J, Zhang M, Yao F, & Cheng Y. Association Between Dynamic Change of QT Interval and Long-Term Cardiovascular Outcomes: A Prospective Cohort Study. Front Cardiovasc Med. 2021;8:756213. YeM ZhangJ LiuJ ZhangM YaoF ChengY Association Between Dynamic Change of QT Interval and Long-Term Cardiovascular Outcomes: A Prospective Cohort Study Front Cardiovasc Med 2021 8 756213 Search in Google Scholar

33. Rabkin SW, Cheng BJ, Thompson DJ. Detailed analysis of the impact of age on the QT interval. J Geriatr Cardiol. 2016;13(9):740–748. RabkinSW ChengBJ ThompsonDJ Detailed analysis of the impact of age on the QT interval J Geriatr Cardiol 2016 13 9 740 748 Search in Google Scholar